U.S. Infrastructure Stock News

As the U.S. stock market retreats from record highs, driven by a downturn in tech stocks, investors are reevaluating their strategies amidst fluctuating economic indicators and potential interest rate adjustments. In this climate, penny stocks remain an intriguing segment for those seeking growth opportunities outside the mainstream indices. Despite being considered a niche area of investment, these smaller or newer companies can offer significant returns when backed by robust financial...

As the U.S. markets experience a slight pullback from record highs, with tech stocks taking a hit and inflation concerns persisting, investors are increasingly looking beyond the giants of Wall Street to find opportunities in lesser-known small-cap companies. In this dynamic environment, identifying stocks that show potential for growth despite broader market fluctuations can be key to uncovering undiscovered gems within the U.S. market.

As the U.S. stock market experiences a pullback from record highs, driven by a decline in tech stocks, investors are increasingly turning their attention to more stable investment options like dividend stocks. In such an environment, dividend-paying stocks can offer a reliable income stream and potential for long-term growth, making them an attractive choice for those looking to navigate market volatility while benefiting from steady returns.

Over the past year, many Howmet Aerospace Inc. ( NYSE:HWM ) insiders sold a significant stake in the company which may...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

There's been a notable change in appetite for Marvell Technology, Inc. ( NASDAQ:MRVL ) shares in the week since its...

Despite an already strong run, CommScope Holding Company, Inc. ( NASDAQ:COMM ) shares have been powering on, with a...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...

The MINISO Group Holding Limited ( NYSE:MNSO ) share price has done very well over the last month, posting an excellent...

American Express just made waves with a major partnership announcement, becoming the official payments partner at Hard Rock Stadium, the Miami Dolphins, and the Formula 1 Miami Grand Prix. This multi-year deal brings exclusive fan perks to eligible cardholders, from presale event tickets to dedicated lounges and entrances. For investors, this is not just marketing; it represents another step in Amex’s expansion of its global sports and entertainment footprint, aimed squarely at deepening...

Pfizer (PFE) just landed a significant regulatory win. On August 27, the company and its partner BioNTech announced that the U.S. Food and Drug Administration approved their updated LP.8.1-adapted monovalent COVID-19 vaccine. This new version is cleared for adults aged 65 and over, as well as younger high-risk individuals, thanks to clinical data showing it provides stronger immune protection against multiple newer COVID strains. For investors wondering where this leaves Pfizer as COVID...

Becton Dickinson recently reported lower-than-expected revenue in the past quarter, citing softness in its research instrument and diagnostics businesses because of reduced global research spending and tariffs. Despite these challenges, the company continues to generate cash and remains committed to shareholder value through ongoing stock buybacks and dividends. We’ll examine how Becton Dickinson’s revenue softness and ongoing shareholder returns may affect the company’s medium-term...

If you’ve been following fuboTV (NYSE:FUBO), you probably noticed the recent 3.3% pop in its share price following the announcement of Fubo Sports, a new standalone streaming plan designed specifically for sports fans. The new tier, set to launch September 2, aims to deliver a focused sports lineup at a lower price point, featuring over 20 national and local channels, plus bundled access to ESPN’s new direct-to-consumer Unlimited plan. This is a move to capture cost-conscious viewers and...

If you own shares of AbbVie or have been watching from the sidelines, the latest wave of clinical trial results may have just put the stock back on your radar. AbbVie has made headlines with positive updates across a handful of key programs, including encouraging data from its pivotal Phase 3 trial of upadacitinib (RINVOQ) in severe alopecia areata as well as early-stage progress in multiple cancer therapies. These developments, paired with upwardly revised earnings estimates, are fueling a...

It is not every day that investors in Berkshire Hathaway (BRK.A) wake up to big news from Omaha. Today’s headline is hard to ignore. Warren Buffett, the titan who has steered the company for decades, will soon hand over the CEO reins to Greg Abel. The announcement that Buffett will step aside as CEO caught the market’s attention, raising questions about leadership, strategy, and what it all means for shareholders. While Buffett plans to remain as chairman, this marks a historic transition for...

V.F (VFC) just got a confidence boost, with Baird upgrading the stock based on signs of a turnaround in the Vans brand, better product momentum, and clear progress on cost-cutting and debt management. This nod from analysts seems to have brightened investor spirits, especially as it lines up with the company’s announced changes to its revolving credit facility, giving them more financial flexibility to support their transformation plans. For shareholders on the sidelines, it is the kind of...

On August 20, 2025, scPharmaceuticals Inc. announced an amendment to its supply agreement with West Pharmaceutical Services, extending the term through December 31, 2027, and clarifying termination cost obligations for both parties. This update highlights both the ongoing relationship around West's SmartDose drug delivery system and the company's continued role as a key supplier in the injectable drug delivery market. We'll explore how the supply agreement extension and terms may impact West...

On August 29, 2025, Reinsurance Group of America filed a shelf registration for a US$241.8 million common stock offering, allocating 1,250,000 shares for its Employee Stock Ownership Plan (ESOP). This ESOP-related capital raise highlights the company's commitment to employee ownership, potentially strengthening alignment between staff interests and long-term corporate performance. We'll examine how this ESOP-driven share offering could influence Reinsurance Group of America's outlook on...

If you own or are eyeing shares of Align Technology (ALGN), the latest string of headlines is hard to ignore. The company’s release of its second-quarter 2025 results fell short of Wall Street expectations, and management trimmed its sales outlook for the rest of the year, citing persistent economic uncertainty and softer demand. In addition, news broke of a securities fraud investigation into Align’s leadership, adding a fresh layer of uncertainty for investors looking to gauge what comes...

EPAM Systems (NYSE:EPAM) is back in the spotlight after reporting quarterly results that beat forecasts, powered by strong demand for AI-focused services and digital modernization. The company also gave its outlook a lift, projecting annual revenue growth of 13% to 15%. Adding to the momentum, EPAM received an analyst upgrade to ‘Buy’, highlighting how three straight quarters of faster organic revenue and its completed post-Ukraine restructuring have changed the conversation for both...

Science Applications International Corporation ( NASDAQ:SAIC ) has announced that it will pay a dividend of $0.37 per...

Bio-Rad Laboratories recently announced the launch of its new StarBright Dyes range, beginning with StarBright UltraViolet700, to enhance spectral flow cytometry applications in immunology research. This product expansion increases the flexibility and compatibility of Bio-Rad’s offerings, potentially strengthening its position within the growing flow cytometry market segment. We'll explore how the addition of StarBright Dyes could enhance Bio-Rad's consumables-driven business and influence...

Brown-Forman (BF.B) Stock: What Do the Latest Earnings Really Mean for Investors? If you own shares of Brown-Forman, or you’re thinking about getting in, the latest quarterly earnings have probably caught your eye. The company’s first-quarter results revealed a decline in both net sales and earnings per share compared to last year. While revenue came in a touch above consensus, that was not quite enough to offset a slide in profitability, and the numbers missed some analysts’ expectations...

Concentrix recently reported quarterly revenues of US$2.42 billion, surpassing analyst expectations by 1.2%, but earnings per share were well below forecast. This contrast between revenue growth and weaker-than-expected profitability reflects ongoing sector challenges such as wage inflation and regulatory pressures. Next, we'll look at how this earnings-per-share shortfall could affect Concentrix's investment narrative and future growth assumptions. Rare earth metals are the new gold rush...